Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EZQ
|
|||
| Former ID |
DIB016146
|
|||
| Drug Name |
AN-1006
|
|||
| Synonyms |
AN 1006; 3',11-Dibutyrylankinomycin; 151283-90-8; AC1L4JTW; an1006; 2-(4,5-Anhydro-1,6-dideoxy-alpha-L-sorbo-2,3-oxiranosyl)-7,12-dihydro-5-methyl-4,7,12-trioxo-10-(2,3,6-trideoxy-3-(dimethylamino)-3-C-methyl-4-O-(1-oxobutyl)-alph-L-lyxo-hexopyranosyl)-4H-anthra(1,2-b)pyran-11-yl butanoate; 2-(4,5-Anhydro-1,6-dideoxy-alpha-L-sorbo-2,3-oxiranosyl)-7,12-dihydro-5-methyl-4,7,12-trioxo-10-(2,3,6-trideoxy-3-(dimethylamino)-3-C-methyl-4-O-(1-oxobutyl)-alpha-L-lyxo-hexopyranosyl)-4H-anthra(1,2-b)pyran-11-yl butanoate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Meiji Seika Kaisha Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C41H47NO11
|
|||
| Canonical SMILES |
CCCC(=O)OC1C(OC(CC1(C)N(C)C)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C5=C(C(=C4)C)C(=O)C=C(O5)C6(C(O6)C7C(O7)C)C)OC(=O)CCC)C
|
|||
| InChI |
1S/C41H47NO11/c1-10-12-28(44)51-36-22(26-18-40(6,42(8)9)38(21(5)48-26)52-29(45)13-11-2)14-15-23-31(36)34(47)32-24(33(23)46)16-19(3)30-25(43)17-27(50-37(30)32)41(7)39(53-41)35-20(4)49-35/h14-17,20-21,26,35,38-39H,10-13,18H2,1-9H3
|
|||
| InChIKey |
JBIOZJJHEWKRHG-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 151283-90-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003022) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.